NuVasive, Inc. NUVA, a medical device company focused on developing minimally
disruptive surgical products and procedures for the spine, announced
today preliminary unaudited information regarding expected revenue
results for the third quarter 2012. NuVasive anticipates revenue for
the third quarter 2012 to be approximately $147 million, which is
below the Company's previous comments that suggested flat sequential
revenue growth compared to $154.4 million in the second quarter 2012.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in